奥浦迈 (688293)
Shanghai OPM Biosciences Co., Ltd.
K-Line Chart
No K-line data available
Company NameShanghai Opumai Biotechnology Co., Ltd.
Listing Date2022-09-02
Issue Price80.2RMB
Registered Capital11382.015410k RMB
Legal RepresentativeXiao Zhihua
Registered AddressNo. 28, Lane 908, Ziping Road, Pudong New District, Shanghai
IndustryBiological Products
Main BusinessResearch, development, and production of cell culture media series products, cell line construction, and cell culture process development, extending to biopharmaceutical CDMO business on this basis.
Company ProfileShanghai Opumai Biotechnology Co., Ltd. is a high-tech enterprise specializing in cell culture products and services. Based on advanced cell culture technology, production processes, and development philosophy, the company integrates cell culture products and services to provide customers with comprehensive solutions, accelerating the process of new drugs from gene (DNA) to Investigational New Drug (IND) application and Biologics License Application (BLA). It aims to reduce the production costs of biopharmaceuticals by optimizing cell culture products and processes. Upholding the core values of 'Achieving Customer Success, Team Collaboration, Openness and Self-Reflection, Pursuit of Excellence', adhering to the quality policy of 'Perfect Craftsmanship, Supreme Quality', and with the mission of 'enabling biopharmaceutical companies to use the most cost-effective cell culture products and services', the company provides high-quality products and services, builds a premium national brand, and supports the rapid development of the biopharmaceutical industry.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor. It is a leading enterprise focusing on automobile manufacturing and intelligent transportation, committed to the research, development and promotion of new energy vehicles and intelligent driving technologies.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital Management | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2,000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities | Securities Company | 1,500 | 3.1 |
| 8 | Guotai Junan Securities | Securities Company | 1,200 | 2.4 |
| 9 | China Merchants Bank | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information